1. Gastritis: 86 gastritis patients took F1 or its modification for up to a month and 8 cured (9.30 percent), 40 significantly improved (46.51 percent), 32 improved (37.20 percent) and six did not improve (6.97 percent).2. Enteritis and dysentery: 148 enteritis patients were divided intom a treatment group (n=106) taking F1 and a comparsion group (n=42) taking regular medications found there was no difference in the cure rate (92.45 vs. 88.09 percent) and the treatment days (2.67 vs. 2.56 days). Pediatric dysentery: 112 children were treated with F1 and all were cured or significantly improved. Stomach ache: 86 patients were divided into a treatment group (n=56) taking F1 and a comparison group (n=30) taking regular stomach ache medications. Cured: 33 vs. 7 (58.92 vs. 23.33 percent); improved: 20 vs. 15 (35.71 vs. 50 percent); not improved: 3 vs. 8 (5.36 vs. 26.67 percent). There is a significant difference between two groups, P<0.005. 3. Impotence: Of 58 patients took F1 or its modifications found 46 cured (79.31 perent), 9 improved (15.51 percent) and three did not improve (5.17 percent). 4.Pediatric poor appetite: 128 patients were treated with F1 r its modification for up to three weeks and 115 cured (89.84 percent) and 13 did not improve (10.15 percent).5. Eczema: 50 patients took F1 or its modification for 15 days found 25 cured, 12 significantly improved, 10 improved and three did not.
